1,1-dichloroethene decreases expression ISO RGD:732999 6480464 vinylidene chloride results in decreased expression of SLCO4A1 mRNA CTD PMID:26682919 17alpha-ethynylestradiol affects expression ISO RGD:732999 6480464 Ethinyl Estradiol affects the expression of SLCO4A1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO RGD:732999 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLCO4A1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SLCO4A1 mRNA CTD PMID:15834898 17alpha-ethynylestradiol increases expression ISO RGD:732999 6480464 Ethinyl Estradiol results in increased expression of SLCO4A1 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:735453 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLCO4A1 mRNA CTD PMID:30165855 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:732999 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:732999 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732999 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLCO4A1 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLCO4A1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732999 6480464 Tetrachlorodibenzodioxin affects the expression of SLCO4A1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732999 6480464 Tetrachlorodibenzodioxin results in increased expression of SLCO4A1 mRNA CTD PMID:17942748 2-butoxyethanol decreases expression ISO RGD:732999 6480464 n-butoxyethanol results in decreased expression of SLCO4A1 mRNA CTD PMID:19812364 2-hydroxypropanoic acid decreases expression ISO RGD:735453 6480464 Lactic Acid results in decreased expression of SLCO4A1 mRNA CTD PMID:30851411 3,4-dichloroaniline increases expression ISO RGD:735453 6480464 3, 4-dichloroaniline results in increased expression of SLCO4A1 mRNA CTD PMID:24172598 3-Iodothyronamine affects uptake ISO RGD:735453 6480464 SLCO4A1 mRNA affects the uptake of 3-iodothyronamine CTD PMID:19074582 4-hydroxyphenyl retinamide increases expression ISO RGD:732999 6480464 Fenretinide results in increased expression of SLCO4A1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SLCO4A1 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of SLCO4A1 mRNA CTD PMID:31881176 acrylamide decreases expression ISO RGD:735453 6480464 Acrylamide results in decreased expression of SLCO4A1 mRNA CTD PMID:32763439 all-trans-retinoic acid decreases expression ISO RGD:735453 6480464 Tretinoin results in decreased expression of SLCO4A1 mRNA CTD PMID:23724009 more ... ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLCO4A1 mRNA CTD PMID:16483693 arsenite(3-) increases expression ISO RGD:735453 6480464 arsenite results in increased expression of SLCO4A1 mRNA CTD PMID:23974009 arsenite(3-) increases methylation ISO RGD:735453 6480464 arsenite results in increased methylation of SLCO4A1 promoter CTD PMID:23974009 benzo[a]pyrene affects methylation ISO RGD:735453 6480464 Benzo(a)pyrene affects the methylation of SLCO4A1 5' UTR, Benzo(a)pyrene affects the methylation of SLCO4A1 exon CTD PMID:27901495 , PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:735453 6480464 Benzo(a)pyrene results in increased methylation of SLCO4A1 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:735453 6480464 7 more ... CTD PMID:19150397 bisphenol A decreases expression ISO RGD:735453 6480464 bisphenol A results in decreased expression of SLCO4A1 mRNA CTD PMID:20678512 bisphenol A decreases methylation ISO RGD:735453 6480464 bisphenol A results in decreased methylation of SLCO4A1 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:732999 6480464 bisphenol A results in decreased expression of SLCO4A1 mRNA CTD PMID:26063408 , PMID:30951980 buta-1,3-diene decreases expression ISO RGD:732999 6480464 1, 3-butadiene results in decreased expression of SLCO4A1 mRNA CTD PMID:29038090 butanal increases expression ISO RGD:735453 6480464 butyraldehyde results in increased expression of SLCO4A1 mRNA CTD PMID:26079696 cadmium atom increases expression ISO RGD:735453 6480464 Cadmium results in increased expression of SLCO4A1 mRNA CTD PMID:23362231 caffeine decreases phosphorylation ISO RGD:735453 6480464 Caffeine results in decreased phosphorylation of SLCO4A1 protein CTD PMID:35688186 cantharidin increases expression ISO RGD:732999 6480464 Cantharidin results in increased expression of SLCO4A1 mRNA CTD PMID:36907384 carbon nanotube increases expression ISO RGD:732999 6480464 Nanotubes more ... CTD PMID:25554681 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of SLCO4A1 mRNA CTD PMID:23125180 chloroprene decreases expression ISO RGD:732999 6480464 Chloroprene results in decreased expression of SLCO4A1 mRNA CTD PMID:23125180 chlorpyrifos increases expression ISO RGD:732999 6480464 Chlorpyrifos results in increased expression of SLCO4A1 mRNA CTD PMID:37019170 cobalt dichloride increases expression ISO RGD:735453 6480464 cobaltous chloride results in increased expression of SLCO4A1 mRNA CTD PMID:19320972 , PMID:19376846 copper atom decreases expression EXP 6480464 Copper results in decreased expression of SLCO4A1 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of SLCO4A1 mRNA CTD PMID:30556269 copper(II) sulfate increases expression ISO RGD:735453 6480464 Copper Sulfate results in increased expression of SLCO4A1 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO RGD:735453 6480464 coumarin results in decreased phosphorylation of SLCO4A1 protein CTD PMID:35688186 crocidolite asbestos increases expression ISO RGD:735453 6480464 Asbestos, Crocidolite results in increased expression of SLCO4A1 mRNA CTD PMID:25351596 cyclosporin A increases expression ISO RGD:735453 6480464 Cyclosporine results in increased expression of SLCO4A1 mRNA CTD PMID:24907557 cyclosporin A decreases expression ISO RGD:735453 6480464 Cyclosporine results in decreased expression of SLCO4A1 mRNA CTD PMID:25562108 dexamethasone increases expression ISO RGD:732999 6480464 Dexamethasone results in increased expression of SLCO4A1 mRNA CTD PMID:22733784 diazinon increases methylation ISO RGD:735453 6480464 Diazinon results in increased methylation of SLCO4A1 gene CTD PMID:22964155 dichloroacetic acid increases expression ISO RGD:732999 6480464 Dichloroacetic Acid results in increased expression of SLCO4A1 mRNA CTD PMID:28962523 dicrotophos decreases expression ISO RGD:735453 6480464 dicrotophos results in decreased expression of SLCO4A1 mRNA CTD PMID:28302478 dioxygen decreases expression ISO RGD:735453 6480464 Oxygen deficiency results in decreased expression of SLCO4A1 mRNA CTD PMID:26516004 dioxygen multiple interactions ISO RGD:732999 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLCO4A1 mRNA CTD PMID:30529165 diuron increases expression ISO RGD:735453 6480464 Diuron metabolite results in increased expression of SLCO4A1 mRNA CTD PMID:24172598 dorsomorphin multiple interactions ISO RGD:735453 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4A1 mRNA CTD PMID:27188386 enilconazole increases expression ISO RGD:735453 6480464 enilconazole results in increased expression of SLCO4A1 mRNA CTD PMID:32201337 entinostat increases expression ISO RGD:735453 6480464 entinostat results in increased expression of SLCO4A1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:735453 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4A1 mRNA CTD PMID:27188386 ethyl methanesulfonate decreases expression ISO RGD:735453 6480464 Ethyl Methanesulfonate results in decreased expression of SLCO4A1 mRNA CTD PMID:23649840 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of SLCO4A1 mRNA CTD PMID:18035473 formaldehyde decreases expression ISO RGD:735453 6480464 Formaldehyde results in decreased expression of SLCO4A1 mRNA CTD PMID:23649840 genistein decreases expression ISO RGD:732999 6480464 Genistein results in decreased expression of SLCO4A1 mRNA CTD PMID:32186404 glyphosate increases methylation EXP 6480464 glyphosate results in increased methylation of SLCO4A1 gene CTD PMID:31011160 ivermectin decreases expression ISO RGD:735453 6480464 Ivermectin results in decreased expression of SLCO4A1 protein CTD PMID:32959892 lead(0) increases expression ISO RGD:735453 6480464 Lead results in increased expression of SLCO4A1 mRNA CTD PMID:23362231 malathion increases expression ISO RGD:735453 6480464 Malathion results in increased expression of SLCO4A1 mRNA CTD PMID:37047231 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of SLCO4A1 mRNA CTD PMID:28801915 methyl methanesulfonate decreases expression ISO RGD:735453 6480464 Methyl Methanesulfonate results in decreased expression of SLCO4A1 mRNA CTD PMID:23649840 mitoxantrone affects response to substance ISO RGD:735453 6480464 SLCO4A1 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 nickel sulfate increases expression ISO RGD:735453 6480464 nickel sulfate results in increased expression of SLCO4A1 mRNA CTD PMID:22714537 paracetamol affects expression ISO RGD:732999 6480464 Acetaminophen affects the expression of SLCO4A1 mRNA CTD PMID:17562736 PCB138 multiple interactions ISO RGD:732999 6480464 [2 more ... CTD PMID:25510870 pentanal increases expression ISO RGD:735453 6480464 pentanal results in increased expression of SLCO4A1 mRNA CTD PMID:26079696 perfluorooctanoic acid decreases expression ISO RGD:735453 6480464 perfluorooctanoic acid results in decreased expression of SLCO4A1 mRNA CTD PMID:36326898 potassium chromate increases expression ISO RGD:735453 6480464 potassium chromate(VI) results in increased expression of SLCO4A1 mRNA CTD PMID:22714537 potassium dichromate increases expression ISO RGD:732999 6480464 Potassium Dichromate results in increased expression of SLCO4A1 mRNA CTD PMID:23608068 pravastatin increases expression EXP 6480464 Pravastatin results in increased expression of SLCO4A1 mRNA CTD PMID:27225895 pravastatin increases expression ISO RGD:732999 6480464 Pravastatin results in increased expression of SLCO4A1 mRNA CTD PMID:27225895 propanal increases expression ISO RGD:735453 6480464 propionaldehyde results in increased expression of SLCO4A1 mRNA CTD PMID:26079696 protein kinase inhibitor multiple interactions ISO RGD:735453 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of SLCO4A1 mRNA] CTD PMID:28003376 pyrazinecarboxamide decreases expression EXP 6480464 Pyrazinamide results in decreased expression of SLCO4A1 mRNA CTD PMID:22431067 quercetin increases expression ISO RGD:735453 6480464 Quercetin results in increased expression of SLCO4A1 mRNA CTD PMID:21632981 quinolin-8-ol increases expression ISO RGD:735453 6480464 Oxyquinoline results in increased expression of SLCO4A1 mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO RGD:735453 6480464 Lactic Acid results in decreased expression of SLCO4A1 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:735453 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SLCO4A1 mRNA CTD PMID:23557933 SB 431542 multiple interactions ISO RGD:735453 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLCO4A1 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:735453 6480464 Silicon Dioxide analog results in increased expression of SLCO4A1 mRNA, Silicon Dioxide results in increased expression of SLCO4A1 mRNA CTD PMID:25351596 , PMID:25895662 sodium arsenite increases expression ISO RGD:735453 6480464 sodium arsenite results in increased expression of SLCO4A1 mRNA CTD PMID:28595984 , PMID:34032870 Soman increases expression EXP 6480464 Soman results in increased expression of SLCO4A1 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:732999 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLCO4A1 mRNA CTD PMID:21641980 , PMID:23086747 tamoxifen decreases expression ISO RGD:732999 6480464 Tamoxifen results in decreased expression of SLCO4A1 mRNA CTD PMID:25123088 tamoxifen affects expression ISO RGD:732999 6480464 Tamoxifen affects the expression of SLCO4A1 mRNA CTD PMID:17555576 tetrachloromethane affects expression ISO RGD:732999 6480464 Carbon Tetrachloride affects the expression of SLCO4A1 mRNA CTD PMID:17484886 titanium dioxide increases expression ISO RGD:732999 6480464 titanium dioxide results in increased expression of SLCO4A1 mRNA CTD PMID:23557971 trichloroethene increases expression ISO RGD:732999 6480464 Trichloroethylene results in increased expression of SLCO4A1 mRNA CTD PMID:25549359 trichostatin A increases expression ISO RGD:735453 6480464 trichostatin A results in increased expression of SLCO4A1 mRNA CTD PMID:24935251 trimellitic anhydride increases expression ISO RGD:732999 6480464 trimellitic anhydride results in increased expression of SLCO4A1 mRNA CTD PMID:19042947 troglitazone decreases expression ISO RGD:732999 6480464 troglitazone results in decreased expression of SLCO4A1 mRNA CTD PMID:28973697 trovafloxacin increases expression ISO RGD:732999 6480464 trovafloxacin results in increased expression of SLCO4A1 mRNA CTD PMID:35537566 valproic acid increases expression ISO RGD:732999 6480464 Valproic Acid results in increased expression of SLCO4A1 mRNA CTD PMID:19136453 , PMID:21427059 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of SLCO4A1 mRNA CTD PMID:32437819 valproic acid affects expression ISO RGD:735453 6480464 Valproic Acid affects the expression of SLCO4A1 mRNA CTD PMID:25979313 valproic acid increases methylation ISO RGD:735453 6480464 Valproic Acid results in increased methylation of SLCO4A1 gene CTD PMID:29154799 vanadium atom decreases expression ISO RGD:735453 6480464 Vanadium results in decreased expression of SLCO4A1 mRNA CTD PMID:19000753 vanadium(0) decreases expression ISO RGD:735453 6480464 Vanadium results in decreased expression of SLCO4A1 mRNA CTD PMID:19000753 withaferin A increases expression ISO RGD:735453 6480464 withaferin A results in increased expression of SLCO4A1 mRNA CTD PMID:33665778 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of SLCO4A1 mRNA CTD PMID:27225895 zaragozic acid A increases expression ISO RGD:732999 6480464 squalestatin 1 results in increased expression of SLCO4A1 mRNA CTD PMID:27225895 zidovudine decreases expression ISO RGD:735453 6480464 Zidovudine results in decreased expression of SLCO4A1 mRNA CTD PMID:24292225 zoledronic acid increases expression ISO RGD:735453 6480464 zoledronic acid results in increased expression of SLCO4A1 mRNA CTD PMID:24714768
